Practice

Congressional Investigations

Strategic advocacy for clients facing congressional investigations and oversight.

Congressional investigations are increasingly high-stakes proceedings that can create significant legal, regulatory, reputational, and business exposure. Foley Hoag represents leading companies, trade associations, boards, and executives before the U.S. House of Representatives, the Senate, and other governmental investigative bodies. From preliminary inquiries and document requests to subpoenas, hearings, and headline-making investigations, we help clients navigate congressional scrutiny with a coordinated strategy designed to protect their interests at every stage.

Our team includes former high-ranking government officials, federal prosecutors, and seasoned defense attorneys who understand how congressional investigations unfold and how parallel enforcement, regulatory, and public-facing risks can develop. Drawing on firsthand experience before House and Senate committees, we help clients anticipate challenges, engage effectively with congressional leadership and staff, and navigate complex interactions with federal agencies and other key stakeholders.

Experience

  • Prepared government officials, including Attorneys General William Barr and John Ashcroft, FBI Director Robert Mueller, and others, for testimony before House and Senate Judiciary and Intelligence Committees on numerous occasions.
  • Represented financial services, technology, education, and other companies in congressional investigations before House and Senate banking, commerce, education, and other committees.
  • Represented former government officials in various public and non-public congressional investigations before both House and Senate committees.
  • Represented a key witness before the House Committee on Ethics in a matter involving alleged bribe payments to a Congressman.
  • Represented former Chief Financial Officer of a major national sports team in a congressional and other investigation.
  • Represented a government official in connection with the Trump impeachment proceedings, including public and non-public appearances before congressional committees.
  • Represented multinational technology and pharmaceutical companies in response to congressional inquiries concerning international tax matters and prepared executives for potential testimony.
  • Counseled numerous leading biopharmaceutical companies during congressional inquiries regarding prescription drug pricing strategies in the United States.
  • Counseled a leading genetic testing company regarding a U.S. House of Representatives investigation into the marketing and claims associated with direct-to-consumer genetic testing.
  • Represented a provider of home and community-based healthcare services in a two-year investigation by the U.S. Senate Finance Committee.
  • Represented a nonprofit organization, its Chief Executive Officer, and other executives in an antitrust investigation conducted by the U.S. House of Representatives Judiciary Committee.

Some of these matters were handled by Foley Hoag attorneys prior to joining Foley Hoag.